Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.

Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.

In vitro studies of the effects of BBR-derived compounds and photodynamic therapy on human glioblastoma cells.

BRESCIANI, GIORGIA
2021/2022

Abstract

Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.
2021
In vitro studies of the effects of BBR-derived compounds and photodynamic therapy on human glioblastoma cells.
Glioblastoma multiforme is one of the most common brain tumors in humans. The average survival after the diagnosis is 12-15 months. The current standard therapy is surgical resection and radiotherapy. In this work, we explore the effects of modified BBR compounds, combined with phototherapy, on GBM cell lines.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14239/14913